Life Sciences Archive » May, 2007

Life Sciences - May, 2007

122 articles

• Court Tosses Verdict, $3M Award Against Wyeth
• California Drops Claims Against Bristol-Myers
• Townsend Steps Up Its Biotech Team
• DenTek Answers Medtech's Infringement Claims
• Consumer Group Backs Purchasers In Fraud Case
• Cordis Gets New Stent Patent, Sues Abbott
• Judge Gives Go-Ahead To Prilosec Patent Suit
• Becton Dickinson Seeks More Time In Antitrust Suit
• Amended Complaint Filed Over Ditropan
• Bristol-Myers Pleads Guilty, Pays $1M In Fines
• Purdue, Impax Patent Fight Comes To An End
• Takeda Files New Suit Against Teva Over Prevacid
• Pfizer To Appeal Lipitor Patents In Norway
• Roche Loses First Accutane Trial, Jury Awards $2.5M
• Uncle Sam Wants You...To Examine Patent Claims
• Whistleblower Suit Against Schering To Proceed
• ITC Once Again Delays Phone Chip Penalty Decision
• House Threatens FDA With Subpoena
• FDA Takes Aim At Unapproved Cough Drugs
• Judge Sets Evidentiary Hearing In Seroquel Case
• Judge Throws Out Slew Of Cases Against Pfizer
• Two Suits Added To OxyContin Antitrust Case
• Life Sciences Industry Says FDA Needs Reform
• Ivax Pushes For Depomed To Share Memos
• Supreme Court Shouldn't Hear Tamoxifen Cases: SG
• ITC To Ban Qualcomm Phone Chips: Experts
• Fresenius Renews Bid To Stay Damages Trial
• Supreme Court Reins In U.S. Patent Law
• Ortho Evra Cases Consolidated In Ohio
• Altana, Sun Squabble Over Discovery Motions
• FDA Issues Warning Over Avandia Amid Outcry
• Open Source's New Weapon: KSR v. Teleflex Ruling
• Counterclaims Filed In HIV Treatment Patent Suit
• Norvasc Patent Still Invalid: Court
• Immucor Settles for $2.5 Million
• Biotech Bankruptcies Face IP Challenges
• Court Lifts Order Barring Teva's Generic Lotrel
• AstraZeneca Sued Over Seroquel Promotions
• MediaTek Dealt Setback In Chip Dispute
• Zydus Takes Aim At Three Rivers' Hep C Patent
• Takeda Sues Over Diabetes Drug Patent
• Leapfrog V. Fisher-Price: Lessons Learned
• Patent Reform Bill Clears First Hurdle
• Boston Scientific Tries To Settle Guidant Claims
• SeraCare Emerges, Settles Securities Suit
• Judge Grants Bid To Toss BioSafe's Ch. 11 Case
• Biotech Co. Fires Back Against Applera
• Merck Files Second Suit Against Teva Over Singulair
• Cases Added to Suit Over Wyeth, Pfizer HRT
• IP Blacklist Lacks Teeth: Experts
• Judge Dismisses Bavarian's Trade Secrets Case
• Abbott Wants New J&J Stent Patent Declared Invalid
• Roche Workers Lose Appeal Of ERISA Claims
• Kinetic, Wake Forest File VAC Patent Complaints
• AstraZeneca Sued Over Breast Cancer Drug
• Sanofi-Aventis Sues To Protect Ambien Market
• FDA Improvement Act Introduced In House
• Abbott Sues To Protect Depakote ER
• Microsoft Seeks New Trial In Patent Case
• KSR Opens Numerous U.S. Patents To Reexamination
• Schering Faces Class Action Over Alleged Kickbacks
• Allergan, Inamed Smooth Out Concerns Over Reloxin
• Supreme Court Won't Touch EPO Patent Spat
• Bad Day At Black Rock II
• Par's ANDA Leads To Infringement Suit
• SEC Sends Biovail Wells Notice
• Edwards Unit Sues Rival Over Catheter Device
• Genendo Loses Drug Importation Appeal
• Wyeth's Sales Tactics Not Anti-Competitive: Court
• AIG Unit Sues Tyco Over Bond Buyback Offer
• Court Keeps Aciphex Free Of Generic Competition
• J&J Keeps Cheap Risperdal Off Shelves
• Plavix Charges Settled, But More May Be Coming
• Digene Loses Belated Bid For Ban On Rival HPV Tests
• Appeals Court Calls LeapFrog's Toy Patent "Obvious"
• U.S. Regulators Crack Down On Medicare Fraud
• Allergan Litigates Over Eye Drop Patent
• Boston Scientific Faces German Patent Suit
• Group Says "Enough" In Pfizer Unit Ch. 11 Case
• Purdue, Employees To Pay $700M In OxyContin Case
• Drug Bill To Change ANDA Petition Process
• Cardinal Health Settles Suit For $600M
• Biovail Chair Fails To Reach Deal With Regulator
• Clinton Unveils Pact To Slash AIDS Drug Prices
• Exxon Seeks Injunction Against Web Domain Buyer
• China's Ex-FDA Head To Go On Trial For Corruption
• District Court Denies Abbott's Motion To Dismiss
• Top Companies Join In Push For Health Care Reform
• Senate Drug Importation Amendment Squashed
• Chevron Nears Iraqi Kickback Settlement: Report
• Purdue Pharma Settles With States Over OxyContin
• Medicis Settles Off-Label Marketing Charges
• Philippines Seeks To Invalidate Pfizer Patent
• Hospital Operator Seeks Transfer Of Antitrust Suit
• U.K. Plaintiffs Dismissed From Hemophilia Case
• Thailand Makes IP Blacklist For Compulsory Licenses
• Lundbeck Loses U.K. Patent Case Over Cipralex
• Study: Bill Could Drive Up Drug Costs by Billions
• PTO Issues Memo On KSR Decision To Examiners
• Judge Excludes Accutane Maker's Own Assessments
• Lawmakers, Unions Fight FDA Plan To Close Labs
• Brazil Breaks Patent On Merck's AIDS Drug
• BioSafe Brokers $6M Deal With Creditors
• KSR v. Teleflex, Redefining The Obvious
• Teleflex Ruling Doesn't Win Vonage New Trial
• German Court OKs Bayer-Schering Merger
• AstraZeneca Warns Against "Procedural Chaos"
• FDA Gives Mylan Tentative OK On Generic Femara
• Reed Smith Nabs Experienced FDA Partner
• Biologics Debated At House Subcommittee Hearing
• Health Plan Contraception Exclusion Not Discriminatory
• Merck Alleges Infringement Of Antibacterial Drug
• EBG Launches Clinical Trial Help Group
• Judge Recommends Revoking Impax's Registration
• Bush Opposes Adding Biologic Generics To FDA Bill
• Bingham McCutchen Joins Forces With Litigation Firm
• Infertility Claim Against Eli Lilly Dismissed
• FDA Attempt To Quash Subpoenas Denied
• Pennsylvania To Review Insurance Merger
• KSR V. Teleflex Creates Uncertainty
• Canadian Court Blocks Generic Celebrex Launch
• New Hampshire Data Law Ruled Unconstitutional